Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Oligonucleotides

Sustainability in Pharmaceutical Manufacture and Healthcare Provision

How do things stand with sustainability in pharmaceutical manufacture at present? What are some members of the industry doing to reduce their carbon footprint?
Read More
Peptides

New peptide with hope of treating triple-negative breast cancer

The preclinical peptide could unlock much needed treatment options for patients with triple-negative breast cancer.
Read More
Biologics Analysis

Overcoming the Hurdles: Navigating the Challenges of Bioconjugate Development

Bioconjugate development, exemplified by ADCs such as T-DM1 and Mylotarg, tackles issues like stability and specificity, benefiting from innovative solutions and services to enhance therapeutic precision in biologics.
Read More
Oligonucleotides

New Approach to Oligo-Peptide Synthesis from Novo and Aarhus University

The collaboration could unlock the more cost-effective synthesis of oligonucleotide-peptide conjugates.
Read More
Proteins & Antibodies

The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma

While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Read More
Proteins & Antibodies

Introducing the Development and Clinical Landscape of Bi and Multispecific Antibodies

While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
Read More
Proteins & Antibodies

Cytokines and Immunocytokines in Therapeutic Approaches 

Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
Read More
Proteins & Antibodies

Post-Event Proceedings - Biologics 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023
Read More
Vaccines

Uncovering the Latest Trends in Vaccine Development and Technology: Advances in Biotechnology and Vaccines

Read More
Proteins & Antibodies

Multispecific Antibody Development: Interview with Yue Liu, President and Founder of Ab Therapeutics

Discussing using a computational drug discovery platform for the development of multispecific antibody therapeutics.
Read More
Vaccines

Strengthening Preparedness for the Next Pandemic: Interview with Ramin Sabet-Azad, CMC Lead, CEPI

How do we prepare for the next pandemic?
Read More
Proteins & Antibodies

Handbook for Stem Cell Research

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics